THB ASSET MANAGEMENT - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 113 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
THB ASSET MANAGEMENT ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q4 2019$2,645,000
-39.7%
46,453
-43.3%
0.49%
-39.7%
Q3 2019$4,386,000
-12.3%
81,955
-2.2%
0.81%
+1.9%
Q2 2019$5,001,000
-8.3%
83,760
-4.3%
0.80%
+0.5%
Q1 2019$5,453,000
-3.8%
87,491
-6.4%
0.79%
-5.9%
Q4 2018$5,667,000
-14.6%
93,520
-17.6%
0.84%
+3.6%
Q3 2018$6,637,000
+29.9%
113,485
-0.4%
0.81%
+30.4%
Q2 2018$5,111,000
+148.6%
113,935
+145.7%
0.62%
+132.0%
Q1 2018$2,056,00046,3700.27%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders